Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)

[1]  Y. Itoyama,et al.  Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesis — decrease in NK cell subset populations and activity in HTLV-I seropositive individuals , 1991, Journal of Neuroimmunology.

[2]  Y. Itoyama,et al.  A Quantitative Polymerase Chain Reaction Study , 2004 .

[3]  A. Fauci,et al.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease , 1990, Nature.

[4]  M. Yoshida,et al.  Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells , 1990, Journal of virology.

[5]  A. Ogata,et al.  Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis , 1990, Journal of the Neurological Sciences.

[6]  Y. Iwasaki.  Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP) , 1990, Journal of the Neurological Sciences.

[7]  D. Mattson,et al.  Immunological studies in tropical spastic paraparesis , 1990, Annals of neurology.

[8]  P. Lipsky,et al.  The role of cell surface recognition structures in the initiation of MHC-unrestricted 'promiscuous' killing by T cells. , 1989, Immunology today.

[9]  G. Moore,et al.  Tropical spastic paraparesis: A model of virus‐induced, cytotoxic T‐cell–mediated demyelination? , 1989, Annals of neurology.

[10]  S. Sonoda,et al.  Increased replication of HTLV‐I in HTLV‐I–associated myelopathy , 1989, Annals of neurology.

[11]  M. Newton,et al.  Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. , 1989, Brain : a journal of neurology.

[12]  Y. Itoyama,et al.  Increases in helper induced T cells and activated T cells in HTLV‐I–associated myelopathy , 1989 .

[13]  H. Sato,et al.  The possible mode of escape of adult T‐cell leukaemia cells from antibody‐dependent cellular cytotoxicity , 1989, British journal of haematology.

[14]  R. Koup,et al.  Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. , 1989, Blood.

[15]  D. Watkins,et al.  A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. , 1989, Disease markers.

[16]  Y. Itoyama,et al.  Expression of HTLV-I antigen in cultured peripheral blood mononuclear cells from patients with HTLV-I associated myelopathy , 1988, Journal of the Neurological Sciences.

[17]  Y. Itoyama,et al.  Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV‐I‐associated myelopathy , 1988, Neurology.

[18]  Y. Itoyama,et al.  Altered subsets of peripheral blood lymphocytes in patients with HTLV‐I associated myelopathy (HAM) , 1988, Neurology.

[19]  M. Osame,et al.  IDENTITY OF HTLV-I-ASSOCIATED TROPICAL SPASTIC PARAPARESIS AND HTLV-I-ASSOCIATED MYELOPATHY , 1988, The Lancet.

[20]  B. Walker,et al.  HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.

[21]  B. Autran,et al.  AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.

[22]  A. Ludolph,et al.  Human T-lymphotropic virus type I antibodies in the serum of patients with tropical spastic paraparesis in the Seychelles. , 1987, Archives of neurology.

[23]  S. Izumo,et al.  Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cells , 1987, Annals of neurology.

[24]  G. de‐Thé,et al.  Endemic tropical spastic paraparesis associated with human T‐lymphotropic virus type I: A clinical and seroepidemiological study of 25 cases , 1987, Annals of neurology.

[25]  M. Setoguchi,et al.  NECROPSY FINDINGS IN HTLV-I ASSOCIATED MYELOPATHY , 1987, The Lancet.

[26]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[27]  Barr,et al.  Classification of Human-Tumors by High-Resolution Magnetic-Resonance Spectroscopy , 1986 .

[28]  D. Gajdusek,et al.  HTLV-I AND HTLV-III ANTIBODIES AND TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[29]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[30]  M. Oldstone,et al.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo , 1984, Journal of virology.

[31]  K. Sugamura,et al.  Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient. , 1984, Journal of immunology.

[32]  B. Rouse,et al.  Role of T-lymphocyte subsets in recovery from herpes simplex virus infection , 1984, Journal of virology.

[33]  H. Mitsuya,et al.  IMMUNE T CELLS REACTIVE AGAINST HUMAN T-CELL LEUKAEMIA/LYMPHOMA VIRUS , 1984, The Lancet.

[34]  P. Bunn,et al.  Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus , 1983, The Journal of experimental medicine.

[35]  K. Sugamura,et al.  Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells. , 1983, Journal of immunology.

[36]  Yuetsu Tanaka,et al.  Monoclonal antibody reactive with both p28 and p19 of adult T-cell leukemia virus-specific polypeptides. , 1983, Gan.

[37]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells , 1983, The Journal of experimental medicine.

[38]  J. Manischewitz,et al.  Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. , 1982, The New England journal of medicine.

[39]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.

[40]  Y. Ohtsuki,et al.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells , 1981, Nature.

[41]  J. Ortaldo,et al.  Natural killer cells: their roles in defenses against disease. , 1981, Science.

[42]  J. H. Pope,et al.  HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Hoffbrand Bi.  Beta-adrenergic blockage in congestive cardiomyopathy. , 1980 .

[44]  Silverman Wa.  Non-treatment of defective newborn babies. , 1980, Lancet.

[45]  A. McMichael,et al.  HLA restriction of cell-mediated lysis of influenza virus-infected human cells , 1977, Nature.

[46]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[47]  J. Kurtzke,et al.  On the evaluation of disability in multiple sclerosis , 1961, Neurology.

[48]  I. Kitajima,et al.  Immunological studies of HTLV-I associated myelopathy. , 1988, Autoimmunity.

[49]  K. Hoeffken,et al.  Letter: Adriamycin in advanced breast cancer. , 1976, Lancet.